| Ytd | 37.74% | |
| 1y | -34.82% |
| Open | 1.45 | Prev Close | 1.47 | Low | 1.45 | High | 1.48 | Mkt Cap | 2.64M |
| Vol | 27.62K | Avg Vol | 2.54M | EPS | -5.44 | P/E | -0.27 | Forward P/E | -0.75 |
| Beta | 0.71 | Short Ratio | 0.12 | Inst. Own | 8.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-12 | 50-d Avg | 1.56 | 200-d Avg | 1.22 | 1yr Est | 20.00 |
INM News
Mentari Therapeutics, a privately held biotechnology enterprise dedicated to preventing migraines, h
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday'
Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#
WALTHAM, Mass., July 22, 2026 /PRNewswire/ -- Mentari Therapeutics, Inc. ("Mentari"), a privately-he
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia and San Francisco, California--(Newsfile Corp. - July 6, 2026) - InMed P
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: I
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and
NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & A
BALA CYNWYD, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it i
/C O R R E C T I O N -- InMed Pharmaceuticals/ PR Newswire VANCOUVER, BC and SAN FRANCISCO, May 19,
US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of InMed Pharmaceuticals,
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports
InMed Pharmaceuticals Inc. (NASDAQ:INM) shares are up during Tuesday's premarket session, as the com
Mentari's parallel lead programs target validated, complementary pathways with potential to address
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: I
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: IN
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
On Tuesday, 386 stocks made new 52-week lows.
GAINERS: EVIO (OTC:EVIO) shares closed up 4900.00% at $5e-05
On Tuesday, 456 stocks hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.